Navigation Links
Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008
Date:7/9/2008

Most Surveyed MCO Pharmacy Directors Will Move Razadyne and Razadyne ER from Tier 2 to Tier 3 When Generic Razadyne is Launched, According to a New

Report from Decision Resources

WALTHAM, Mass., July 9 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the generic availability of Shire/Janssen/Ortho McNeil's Razadyne (galantamine) in December 2008 will have the greatest impact on Eisai/Pfizer's Aricept as surveyed primary care physicians (PCPs) estimate that after the launch of generic galantamine, prescriptions of Aricept for the treatment of Alzheimer's disease will drop by up to 20 percent. According to the new Physician & Payer Forum primary market research report entitled The Impact of Razadyne's Genericization and the Launch of Biologic Disease-Modifying Drugs on the Alzheimer's Disease Market: Clinician and Payer Receptivity to Novel Agents, the availability of generic galantamine will decrease Aricept's share of PCPs' prescriptions for Alzheimer's disease patients from 66 percent to 46 percent by December 2009. The report also finds that for surveyed neurologists, Aricept's share of prescriptions for Alzheimer's disease patients will fall from 62 percent to 44 percent.

According to the report, more than two-thirds of managed care organizations (MCOs) that cover Razadyne and Razadyne ER in their private plan formularies grant these agents tier 2 status. When generic galantamine becomes available, many surveyed MCO pharmacy directors indicated that they will move both Razadyne formulations to tier 3. Additionally, nearly one quarter of surveyed MCO pharmacy directors said they will remove Razadyne ER from their private plan formularies, and more than one third will remove Razadyne, when generic galantamine becomes available. The percentage of pharmacy directors who reported they will remove Razadyne ER and Razadyne from their
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
2. Study finds primary care depression treatment often does not follow quality guidelines
3. Primary biliary cirrhosis more severe in African-American and Hispanic patients
4. New research may lead to earlier diagnosis and treatment of primary biliary cirrhosis in families
5. Revisions to College Cost Reduction and Access Act will create barriers to primary care
6. New Hampshire: 1st in the Nation Primary State Takes a Stand on E-Prescribing
7. Editorial says primary care system must change how it approaches dementia
8. S&P: Leverage Tops Politics as Primary Credit Concern for U.S. Health Care Companies, Says S&P
9. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
10. Visual field loss primary component in risk of falls for older adults
11. Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...S,Nov.27/PRNewswire-USNewswire/--Consideredahighly...o,solidorgantransplantationisnowalife-savingmainst...ogatheredattheWinspearOperaHouseinDallasonNov.11.L...tocelebratethe25thanniversaryofBaylorRegionalTrans...ransplantintheUnitedStates. ,, Itwas25yearsagot...
(Date:11/27/2009)...LY-SUR-SEINE,France,Nov.27/PRNewswire/--TeamGarmin...mdedicatedtoethicalsportinganddevelopingthenextgen...becomeTeamGarmin-TransitionswiththeadditionofTrans...icalistheworld,sleadingmanufacturerofadaptiveeyewe...thewidestselectionofspectaclelensessuchasTransitio...
(Date:11/27/2009)...ycling plus low-emission vehicles may reduce futur...IDAY, Nov. 27 (HealthDay News) -- Encouraging city...s would offer much greater public health benefits ... researchers have found. , The study compared t... urban land transport scenarios for London, Englan...
(Date:11/27/2009)... Voyant Health™ announced today ...licensed its TraumaCad Enterprise orthopedic templ...olution. , (PRWEB) Novemb...y that Spectrum Health (Grand Rapids, Michigan) ha...plating solution and its TraumaCad Extend workflow...
(Date:11/27/2009)... Three new interactive anatomy educati...; Wilkins expand health sciences learning opportun... Durham, NC (Vocus) November 27, 2009 -- ...ins (LWW), a division of Wolters Kluwer Health, to...y education apps on the App Store. Clemente’...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5
...e light on mysterious condition , , WEDNES... that may increase the risk of autism, particularl.... , Analysis of the DNA of 1,046 members of famili...utism, the researchers reported. , This variant of...
...re in people with Down syndrome, whose overall can...eneral population. Since they have an extra copy o...th Down syndrome may be getting an extra dose of o...n, popularized the notion that they might be benef...
...hlighted in June 2009 issue of Pregnancy , , BAL...ookin.com its "Website We Can,t Live Without" for ... provides information on bed rest and preterm la...lace to talk about it, on the online forum," says ...
...California $70 Million In Health Care Costs And Pr...lose September 2009 , , SAN FRANCISCO, May 20 Fu...ely eliminated from the California state budget. B...cal professionals. , , The California Poison Con...
... Orasi Medical, Inc. announced today that it has ... , , The company will use this capital to expand ...o the pharmaceutical and clinical markets. Pharmac...cussions with several pharmaceutical companies to ...
...p Designed to Urge Families to Take Action against... AstraZeneca (NYSE: AZN ) today kicks off the 20...Artery Explorer -- a state-of-the-art, multisensor... a row, AstraZeneca has partnered with the Nationa...
Other Medicine News:Health News:Gene Gives Clues to Why Autism More Common in Boys 2Health News:Why do people with Down syndrome have less cancer? 2Health News:Why do people with Down syndrome have less cancer? 3Health News:Pregnancy Magazine Names KeepEmCookin.com its 'Website We Can't Live Without' 2Health News:Governor Eliminates California's Poison Control Service 2Health News:AstraZeneca, the National Alliance for Hispanic Health and LULAC Join Forces to Promote Needed Heart Health Education in Hispanic Communities 2Health News:AstraZeneca, the National Alliance for Hispanic Health and LULAC Join Forces to Promote Needed Heart Health Education in Hispanic Communities 3Health News:AstraZeneca, the National Alliance for Hispanic Health and LULAC Join Forces to Promote Needed Heart Health Education in Hispanic Communities 4Health News:AstraZeneca, the National Alliance for Hispanic Health and LULAC Join Forces to Promote Needed Heart Health Education in Hispanic Communities 5
(Date:11/25/2009)...,, WESTPALMBEACH,Fla.,Nov.25/PRNewswire-First...ans,especiallythe27millionlivingwithuntreated hear...logistCindyBeyer. ,, Dr.Beyer,seniorvicepreside...ngcareand hearingaids companies,saidstudieshavelin...ion,"whichcaneasilybeintensifiedatholidaygathering...
(Date:11/25/2009)...,, HARBIN,China,Nov.25/PRNewswire-Asia-FirstC..."or"theCompany")(Nasdaq: CSKI ),a,leadingfullyinte...over-the-counterdrugsinthePeople,sRepublicofChina(...theChineseNationalInstitutefor,theControlofPharmac...ortwoofitsnewproducts:itsDiagnosticKitforHumanPros...
(Date:11/25/2009)...,, EASTBRUNSWICK,N.J.,Nov.25/PRNewswire/--Swi...tdigitalRadiography( ddR )systems,announcedtodayth...storwithalongtermviewtowardsgrowingSwissray,smedic...ntellectualproperty,aswellascontractsandinventory....omovetothenextleveloftechnologicaladvancementswith...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Swissray International Announces New Ownership 2Local Medicare Advantage Plan Gets Five Star Ratings from Medicare 60771 1Local Medicare Advantage Plan Gets Five Star Ratings from Medicare 60771 2Local Medicare Advantage Plan Gets Five Star Ratings from Medicare 60771 3The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit 3B State Investigation Finds Evidence of Negligence at Woodbridge Day School 60768 1The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit 3B State Investigation Finds Evidence of Negligence at Woodbridge Day School 60768 2ChemSW Rated Top Vendor Overall for Customer Satisfaction in Q3 2009 by VendorRate 60765 1ChemSW Rated Top Vendor Overall for Customer Satisfaction in Q3 2009 by VendorRate 60765 2
...efer Orapred ODT Over Liquid, ALPHARETTA, Ga., Mar...s announced today survey results showing that,chil...hosphate,orally disintegrating tablets) over liqui...ck survey involving more than,900 children (n=973)...d Orapred ODT over liquid versions. The results al...
...7 /PRNewswire-FirstCall/ -- Baxter,International I...adjuvant-free investigational pandemic H5N1 influe...ical trial of the candidate,vaccine in Europe to c...ndicated that Baxter,s H5N1 candidate,vaccine is h...ntial,levels of cross immunity against widely dive...
Other Medicine Technology:Orapred ODT Tastes Good 2Orapred ODT Tastes Good 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5
Digital Microscope Camera - DMC2
Bench Top Vertical Airflow Cabinets Production Protection
Console Horizontal Airflow Cabinet
Heated Processing Chamber
Medicine Products: